Acquisition of meiotic DNA repair regulators maintain genome stability in glioblastoma

Por Rivera, M, Wu, Q, Hamerlik, P, Hjelmeland, A B, Bao, S, Rich, J N
Publicado no Cell Death Dis (2015)

P08.18 Replication stress as a driver of genomic instability in malignant gliomas

Por Rasmussen, R., Gajjar, M., Tuckova, L., Jensen, K., Maya-Mendoza, A., Bartek, J., Hamerlik, P.
Publicado no Neuro Oncol (2017)

P08.06 Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

Por Urup, T., Staunstrup, L., Michaelsen, S., Vitting-Seerup, K., Bennedbæk, M., Toft, A., Broholm, H., Hamerlik, P., Poulsen, H., Lassen, U.
Publicado no Neuro Oncol (2016)

P01.12 VEGF-C contributes to autocrine VEGF Receptor 2 signaling and cellular maintenance in Glioblastoma

Por Michaelsen, S. R., Nedergaard, M. K., Broholm, H., Bartkova, J., Staberg, M., Aghi, M., Lucacova, S., Perryman, L., Poulsen, H. S., Hamerlik, P.
Publicado no Neuro Oncol (2016)

Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact

Por Fornara, O, Bartek Jr, J, Rahbar, A, Odeberg, J, Khan, Z, Peredo, I, Hamerlik, P, Bartek, J, Stragliotto, G, Landázuri, N, Söderberg-Nauclér, C
Publicado no Cell Death Differ (2016)

Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells

Por Venere, M, Hamerlik, P, Wu, Q, Rasmussen, R D, Song, L A, Vasanji, A, Tenley, N, Flavahan, W A, Hjelmeland, A B, Bartek, J, Rich, J N
Publicado em 2014